Expanded FDA emergency use authorization would allow for the use of the COVID-19 vaccine candidate, which has full FDA approval for people 16 years of age and older, in children aged 5 to 11. It received an EUA for adolescents aged 12 to 15 in May.
Get the full story at our sister site, Drug Discovery & Development.